You are here

Lexaria Bioscience Corp.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Diversified Industries
Symbol: 
LXX
CSE Index: 
Currency: 

Lexaria Bioscience Corp. has developed and out-licenses its disruptive technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and was granted its first patents in the USA and in Australia related to edible forms of cannabinoids. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),  nicotine and other molecules.

 

You are here

Lexaria Bioscience Corp. (LXX)

SEDAR Information

Company Info

Address
#100 - 740 McCurdy Rd.,
Kelowna, BC V1X 2P7
Canada
Phone
1-250-765-6424
Fax
1-250-765-2599
Email
cbunka@lexariabioscience.com
Website
http://www.lexariabioscience.com
Listing date
Wednesday, October 28, 2009
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
Alex Blanchard
Email
ablanchard@lexariabioscience.com
Auditor
Davidson & Company LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
77,370,421
Reserved for Issuance: 
9,094,607

Company Officers

Chris Bunka, CEO
John Docherty, President
Allan Spissinger CPA, CA, CFO

Bulletins

10/05/2016

2016-0507 – Name Change - Lexaria Corp. (LXX)

 

Lexaria Corp. has announced a name change to Lexaria Bioscience Corp.

Shares will begin trading under the new name on Thursday, May 12, 2016.

Disclosure documents are available www.thecse.com

Please note the CUSIP, ISIN and symbol will remain the same.

Effective Date: May 12, 2016

If you have any questions or require further information, please contact Listings at (416) 367-7340 or E-mail:  Listings@thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

11_12_Northwind_Forum_Website

Northwind’s 13th Annual Capital Markets Invitational Forum

Tuesday, November 12, 2019 (All day) to Wednesday, November 13, 2019 (All day)
11_12_2nd_Annual_Boston_Cannabis_Conference_Website

2nd Annual Boston Cannabis Conference

Tuesday, November 12, 2019 (All day) to Wednesday, November 13, 2019 (All day)